During the past decade, Female Pelvic Medicine & Urogynecology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Female Pelvic Medicine & Urogynecology" #1 sponsor was "Allergan" with 1 trials, followed by "Coloplast A/S" with 1 trials sponsored, "Ethicon, Inc." with 1 trials sponsored, "Integra LifeSciences Corporation" with 1 trials sponsored and "TherapeuticsMD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Female Pelvic Medicine & Urogynecology" #1 collaborator was "TARIS Biomedical, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Female Pelvic Medicine & Urogynecology" are "Pelvic Organ Prolapse" (2 trials), "Interstitial Cystitis" (1 trials), "Menopause" (1 trials) and "Stress Urinary Incontinence" (1 trials). Many other conditions were trialed in "Female Pelvic Medicine & Urogynecology" in a lesser frequency.

Most popular intervention types in "Female Pelvic Medicine & Urogynecology" are "Device" (3 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Altis Sling" (1 trials), "Estradiol" (1 trials), "GYNECARE PROSIMA* Pelvic Floor Repair System" (1 trials), "LiRIS Placebo" (1 trials) and "Lidocaine Releasing Intravesical System - LiRIS®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Female Pelvic Medicine & Urogynecology" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Female Pelvic Medicine & Urogynecology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Female Pelvic Medicine & Urogynecology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Female Pelvic Medicine & Urogynecology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".